The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Detection of SARS Coronavirus in Patients with Suspected SARS
Open accessAbstract
Cases of severe acute respiratory syndrome (SARS) were investigated for SARS coronavirus (SARS-CoV) through RNA tests, serologic response, and viral culture.Of 537 specimens from patients in whom SARS was clinically diagnosed, 332 (60%) had SARS-CoV RNA in one or more clinical specimens, compared with 1 (0.3%) of 332 samples from controls.Of 417 patients with clinical SARS from whom paired serum samples were available, 92% had an antibody response.Rates of viral RNA positivity increased progressively and peaked at day 11 after onset of illness.Although viral RNA remained detectable in respiratory secretions and stool and urine specimens for >30 days in some patients, virus could not be cultured after week 3 of illness.Nasopharyngeal aspirates, throat swabs, or sputum samples were the most useful clinical specimens in the first 5 days of illness, but later in the illness viral RNA could be detected more readily in stool specimens.I n early 2003, severe acute respiratory syndrome (SARS) was recognized as a newly emerging pneumonic disease (1-3).A proportion of patients have watery diarrhea, usually at a later stage of the illness, suggesting that the infection may not be confined to the respiratory tract (4).A novel coronavirus, designated as SARS coronavirus (SARS-CoV), was implicated as the causative agent (5-7), and the respiratory disease has been reproduced in a nonprimate animal model (8).Hong Kong was one of the regions most affected, with >1,700 patients.Specific laboratory tests to detect viral RNA and antibody responses (5) were used to establish a cause in patients suspected to have SARS.Although virologic results for small cohorts of patients have been reported (4,5,9), analysis of results of these first-generation tests in routine clinical practice has not been published previously.We report the correlation of results of reverse transcriptase polymerase chain reaction (RT-PCR) and immunofluorescent serologic testing for SARS-CoV in 1,048 cases investigated for SARS in the first 5 weeks after the first-generation diagnostic tests became available in Hong Kong. Methods PatientsIn the weeks after the first-generation viral diagnostic tests became available in Hong Kong, SARS-CoV diagnosis was carried out in three laboratories, one of which was the Department of Microbiology of Queen Mary Hospital (QMH).Results from specimens investigated at QMH laboratory from April 1 through May 3, 2003, and subsequent follow-up specimens are included in this analysis.Clinical specimens used for viral RNA detection included nasopharyngeal aspirates, throat and nose swabs, saliva, sputum, endotracheal aspirates, feces, and urine.Nasopharyngeal aspirates were collected into a mucus trap, and residual secretions in the catheter were sucked into the trap by aspirating 2 mL of virus transport medium.Swabs were collected into 2 mL of virus transport medium containing vancomycin (final concentration 100 µg/mL), amikacin (30 µg/mL), and nystatin (40 U/mL).Urine and feces were collected into specimen containers and submitted directly to the laboratory without the addition of transport medium.The case definition has been previously described (5,10).Patients were categorized on a clinical basis as "clinical SARS," "suspected SARS," and "not SARS" by the attending clinicians, depending on the response to antimicrobial therapy for bacterial pathogens (e.g., tazocin 2.25-4.5 g intravenously 6-8 h/d, or azithromycin 500 mg/d for 7-10/d), the clinical and radiologic evolution of the illness, history of contact with other patients with SARS, and an alternative diagnosis that fully explained the clinical findings.Fecal, throat swab, and serum specimens from controls were obtained for comparison.Fecal specimens from patients with diarrhea were anonymously tested for SARS-CoV RNA.Throat swab specimens were collected after informed consent from patients attending primary care Detection of SARS Coronavirus inPatients with Suspected SARS
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,344
Coronavirus as a possible cause of severe acute respiratory syndrome
Peiris, J., Lai, S., Poon, L., Guan, Y., Yam, L., Lim, W., Nicholls, J., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,915
Self-citationA Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
Lee, N., Hui, D., Wu, A., Chan, P., Cameron, P., Joynt, G. M., Ahuja, A., Yung, M. Y., Leung, C. B., To, K. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030685 · Cited by 2,628
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375
Self-citationTransmission Dynamics and Control of Severe Acute Respiratory Syndrome
Lipsitch, M., Cohen, T., Cooper, B., Robins, J. M., Ma, S., James, L., Gopalakrishna, G., Chew, S. K., Tan, C. C., Samore, M. H., et al. (2003) · Science · doi:10.1126/science.1086616 · Cited by 1,485
A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong
Tsang, K. W., Ho, P. L., Ooi, G. C., Yee, W. K., Wang, T., Chan-Yeung, M., Lam, W. K., Seto, W. H., Yam, L. Y., Cheung, T. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030666 · Cited by 1,017
Self-citationDonnelly, C. A., Ghani, A. C., Leung, G. M., Hedley, A. J., Fraser, C., Riley, S., Abu-Raddad, L. J., Ho, L.-M., Thach, T.-Q., Chau, P., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13410-1 · Cited by 940
Self-citationKoch's postulates fulfilled for SARS virus
Fouchier, R. A. M., Kuiken, T., Schutten, M., van Amerongen, G., van Doornum, G. J. J., van den Hoogen, B. G., Peiris, M., Lim, W., Stöhr, K., & Osterhaus, A. D. M. E. (2003) · Nature · doi:10.1038/423240a · Cited by 789
Early diagnosis of SARS Coronavirus infection by real time RT-PCR
Poon, L. L. M., Chan, K. H., Wong, O. K., Yam, W. C., Yuen, K. Y., Guan, Y., Lo, Y. M. D., & Peiris, J. S. M. (2003) · Journal of Clinical Virology · doi:10.1016/j.jcv.2003.08.004 · Cited by 198
Self-citation
Cited by
Cheung, K. S., Hung, I. F. N., Chan, P. P. Y., Lung, K. C., Tso, E., Liu, R., Ng, Y. Y., Chu, M. Y., Chung, T. W. H., Tam, A. R., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.065 · Cited by 1,631
Self-citationCOVID‐19 diagnosis and management: a comprehensive review
Pascarella, G., Strumia, A., Piliego, C., Bruno, F., Del Buono, R., Costa, F., Scarlata, S., & Agrò, F. E. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13091 · Cited by 1,369
Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection
Cheng, V. C. C., Lau, S. K. P., Woo, P. C. Y., & Yuen, K. Y. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-07 · Cited by 1,192
Self-citationRole of angiotensin-converting enzyme 2 (ACE2) in COVID-19
Ni, W., Yang, X., Yang, D., Bao, J., Li, R., Xiao, Y., Hou, C., Wang, H., Liu, J., Yang, D., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03120-0 · Cited by 1,175
Severe acute respiratory syndrome
Peiris, J. S. M., Guan, Y., & Yuen, K. Y. (2004) · Nature Medicine · doi:10.1038/nm1143 · Cited by 1,139
Self-citationChan, J. F. W., Lau, S. K. P., To, K. K. W., Cheng, V. C. C., Woo, P. C. Y., & Yuen, K.-Y. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-14 · Cited by 881
Self-citationEnteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?
Yeo, C., Kaushal, S., & Yeo, D. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30048-0 · Cited by 817
Covid‐19 and the digestive system
Wong, S. H., Lui, R. N., & Sung, J. J. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15047 · Cited by 713
Lu, X., Wang, L., Sakthivel, S. K., Whitaker, B., Murray, J., Kamili, S., Lynch, B., Malapati, L., Burke, S. A., Harcourt, J., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2608.201246 · Cited by 676
Gut microbiota and Covid-19- possible link and implications
Dhar, D., & Mohanty, A. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198018 · Cited by 608
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus
Jeffers, S. A., Tusell, S. M., Gillim-Ross, L., Hemmila, E. M., Achenbach, J. E., Babcock, G. J., Thomas, W. D., Thackray, L. B., Young, M. D., Mason, R. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403812101 · Cited by 605
Pathology and Pathogenesis of Severe Acute Respiratory Syndrome
Gu, J., & Korteweg, C. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.061088 · Cited by 592
Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction
Corman, V. M., Eckerle, I., Bleicker, T., Zaki, A., Landt, O., Eschbach-Bludau, M., van Boheemen, S., Gopal, R., Ballhause, M., Bestebroer, T. M., et al. (2012) · Eurosurveillance · doi:10.2807/ese.17.39.20285-en · Cited by 561
Immunopathogenesis of coronavirus infections: implications for SARS
Dandekar, A. A., & Perlman, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1732 · Cited by 499
Liang, M., Gao, L., Cheng, C., Zhou, Q., Uy, J. P., Heiner, K., & Sun, C. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101751 · Cited by 470
Cheung, C. Y., Poon, L. L. M., Ng, I. H. Y., Luk, W., Sia, S.-F., Wu, M. H. S., Chan, K.-H., Yuen, K.-Y., Gordon, S., Guan, Y., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7819-7826.2005 · Cited by 461
Self-citationSerological assays for emerging coronaviruses: Challenges and pitfalls
Meyer, B., Drosten, C., & Müller, M. A. (2014) · Virus Research · doi:10.1016/j.virusres.2014.03.018 · Cited by 410
Kariwa, H., Fujii, N., & Takashima, I. (2006) · Dermatology · doi:10.1159/000089211 · Cited by 458
Corman, V. M., Albarrak, A. M., Omrani, A. S., Albarrak, M. M., Farah, M. E., Almasri, M., Muth, D., Sieberg, A., Meyer, B., Assiri, A. M., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ951 · Cited by 374
SARS-CoV-2 from faeces to wastewater treatment: What do we know? A review
Foladori, P., Cutrupi, F., Segata, N., Manara, S., Pinto, F., Malpei, F., Bruni, L., & La Rosa, G. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.140444 · Cited by 370
Yan, Y., Chang, L., & Wang, L. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2106 · Cited by 306
Pekosz, A., Parvu, V., Li, M., Andrews, J. C., Manabe, Y. C., Kodsi, S., Gary, D. S., Roger-Dalbert, C., Leitch, J., & Cooper, C. K. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1706 · Cited by 276
To, K., & Lo, A. W. (2004) · The Journal of Pathology · doi:10.1002/path.1597 · Cited by 226
“Similarly, the presence of virus in the distal convoluted tubules of the kidney is consistent with detection of the viral genome in urine and suggests that urine may be an additional source of sewage contamination [28].”
BackgroundKutter, J. S., de Meulder, D., Bestebroer, T. M., Lexmond, P., Mulders, A., Richard, M., Fouchier, R. A. M., & Herfst, S. (2021) · Nature Communications · doi:10.1038/s41467-021-21918-6 · Cited by 176
Metadata
- Authors
- Chan, K. H., Poon, L. L. L. M., Cheng, V. C. C., Guan, Y., Hung, I. F. N., Kong, J., Yam, L. Y. C., Seto, W. H., Yuen, K. Y., & Peiris, J. S. M.
- Venue
- Emerging Infectious Diseases
- Published
- 2004-02
- Volume
- 10
- Issue
- 2
- Pages
- 294-299
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2161315652
- Cited by
- 314
- References
- 16
- FWCI
- 14.40
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.